Moorfields Pharmaceuticals recalls selected batches of bevacizumab intravitreal injection 1.25mg/0.05ml following reports of suspected sterile endophthalmitis

Source: MHRA
Area: News
Moorfields Pharmaceuticals has issued a precautionary recall of selected lots (see list of batch numbers in document at link below) of bevacizumab intravitreal injection 1.25mg/0.05ml following a number of reports of suspected sterile endophthalmitis. This is listed in the Summary of Product Characteristics (SPC) for Avastin, when used off-label, but the number of reports is higher than with previous batches and a precautionary recall has been instigated.   For stock enquiries, contact Customer Services Department on 020 7684 9090 (Option 1) or email: Pharmaceuticals@moorfields.nhs.uk For medical (Read more...)

Full Story →